Literature DB >> 26230658

Igfbp2 Deletion in Ovariectomized Mice Enhances Energy Expenditure but Accelerates Bone Loss.

Victoria E DeMambro1, Phuong T Le1, Anyonya R Guntur1, David E Maridas1, Ernesto Canalis1, Kenichi Nagano1, Roland Baron1, David R Clemmons1, Clifford J Rosen1.   

Abstract

Previously, we reported sexually dimorphic bone mass and body composition phenotypes in Igfbp2(-/-) mice (-/-), where male mice exhibited decreased bone and increased fat mass, whereas female mice displayed increased bone but no changes in fat mass. To investigate the interaction between IGF-binding protein (IGFBP)-2 and estrogen, we subjected Igfbp2 -/- and +/+ female mice to ovariectomy (OVX) or sham surgery at 8 weeks of age. At 20 weeks of age, mice underwent metabolic cage analysis and insulin tolerance tests before killing. At harvest, femurs were collected for microcomputed tomography, serum for protein levels, brown adipose tissue (BAT) and inguinal white adipose tissue (IWAT) adipose depots for histology, gene expression, and mitochondrial respiration analysis of whole tissue. In +/+ mice, serum IGFBP-2 dropped 30% with OVX. In the absence of IGFBP-2, OVX had no effect on preformed BAT; however, there was significant "browning" of the IWAT depot coinciding with less weight gain, increased insulin sensitivity, lower intraabdominal fat, and increased bone loss due to higher resorption and lower formation. Likewise, after OVX, energy expenditure, physical activity and BAT mitochondrial respiration were decreased less in the OVX-/- compared with OVX+/+. Mitochondrial respiration of IWAT was reduced in OVX+/+ yet remained unchanged in OVX-/- mice. These changes were associated with significant increases in Fgf21 and Foxc2 expression, 2 proteins known for their insulin sensitizing and browning of WAT effects. We conclude that estrogen deficiency has a profound effect on body and bone composition in the absence of IGFBP-2 and may be related to changes in fibroblast growth factor 21.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26230658      PMCID: PMC4606757          DOI: 10.1210/en.2014-1452

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  59 in total

1.  Estradiol replacement alters expression of genes related to neurotransmission and immune surveillance in the frontal cortex of middle-aged, ovariectomized rats.

Authors:  Miklós Sárvári; Imre Kalló; Erik Hrabovszky; Norbert Solymosi; Kinga Tóth; István Likó; Béla Molnár; Károly Tihanyi; Zsolt Liposits
Journal:  Endocrinology       Date:  2010-06-09       Impact factor: 4.736

2.  An automated algorithm to detect the trabecular-cortical bone interface in micro-computed tomographic images.

Authors:  Svetlana Lublinsky; Engin Ozcivici; Stefan Judex
Journal:  Calcif Tissue Int       Date:  2007-09-09       Impact factor: 4.333

3.  The skeleton and the sympathetic nervous system: it's about time!

Authors:  Katherine J Motyl; Clifford J Rosen
Journal:  J Clin Endocrinol Metab       Date:  2012-11       Impact factor: 5.958

Review 4.  The role of leptin and ghrelin in the regulation of food intake and body weight in humans: a review.

Authors:  M D Klok; S Jakobsdottir; M L Drent
Journal:  Obes Rev       Date:  2007-01       Impact factor: 9.213

5.  Propranolol Attenuates Risperidone-Induced Trabecular Bone Loss in Female Mice.

Authors:  Katherine J Motyl; Victoria E DeMambro; Deborah Barlow; David Olshan; Kenichi Nagano; Roland Baron; Clifford J Rosen; Karen L Houseknecht
Journal:  Endocrinology       Date:  2015-04-08       Impact factor: 4.736

6.  Bone mass increase specific to the female in a line of transgenic mice overexpressing human osteoblast stimulating factor-1.

Authors:  Tamotsu Hashimoto-Gotoh; Hideo Ohnishi; Atsushi Tsujimura; Hiroaki Tsunezuka; Kan Imai; Haruchika Masuda; Toshitaka Nakamura
Journal:  J Bone Miner Metab       Date:  2004       Impact factor: 2.626

7.  Gender-specific changes in bone turnover and skeletal architecture in igfbp-2-null mice.

Authors:  V E DeMambro; D R Clemmons; L G Horton; M L Bouxsein; T L Wood; W G Beamer; E Canalis; C J Rosen
Journal:  Endocrinology       Date:  2008-02-14       Impact factor: 4.736

8.  A potentially deleterious role of IGFBP-2 on bone density in aging men and women.

Authors:  Shreyasee Amin; B Lawrence Riggs; Elizabeth J Atkinson; Ann L Oberg; L Joseph Melton; Sundeep Khosla
Journal:  J Bone Miner Res       Date:  2004-03-22       Impact factor: 6.741

9.  Insulin-like growth factor (IGF) binding protein 2 functions coordinately with receptor protein tyrosine phosphatase β and the IGF-I receptor to regulate IGF-I-stimulated signaling.

Authors:  Xinchun Shen; Gang Xi; Laura A Maile; Christine Wai; Clifford J Rosen; David R Clemmons
Journal:  Mol Cell Biol       Date:  2012-08-06       Impact factor: 4.272

10.  A PGC1-α-dependent myokine that drives brown-fat-like development of white fat and thermogenesis.

Authors:  Pontus Boström; Jun Wu; Mark P Jedrychowski; Anisha Korde; Li Ye; James C Lo; Kyle A Rasbach; Elisabeth Almer Boström; Jang Hyun Choi; Jonathan Z Long; Shingo Kajimura; Maria Cristina Zingaretti; Birgitte F Vind; Hua Tu; Saverio Cinti; Kurt Højlund; Steven P Gygi; Bruce M Spiegelman
Journal:  Nature       Date:  2012-01-11       Impact factor: 49.962

View more
  18 in total

1.  Mesenchymal stem cells gene signature in high-risk myeloma bone marrow linked to suppression of distinct IGFBP2-expressing small adipocytes.

Authors:  Syed J Mehdi; Sarah K Johnson; Joshua Epstein; Maurizio Zangari; Pingping Qu; Antje Hoering; Frits van Rhee; Carolina Schinke; Sharmilan Thanendrarajan; Bart Barlogie; Faith E Davies; Gareth J Morgan; Shmuel Yaccoby
Journal:  Br J Haematol       Date:  2018-11-08       Impact factor: 6.998

2.  Estrogen Stimulation of Pleiotrophin Enhances Osteoblast Differentiation and Maintains Bone Mass in IGFBP-2 Null Mice.

Authors:  Gang Xi; Victoria E Demambro; Susan D'Costa; Shalier K Xia; Zach C Cox; Clifford J Rosen; David R Clemmons
Journal:  Endocrinology       Date:  2020-04-01       Impact factor: 4.736

3.  Isolation, Culture, and Differentiation of Bone Marrow Stromal Cells and Osteoclast Progenitors from Mice.

Authors:  David E Maridas; Elizabeth Rendina-Ruedy; Phuong T Le; Clifford J Rosen
Journal:  J Vis Exp       Date:  2018-01-06       Impact factor: 1.355

4.  Spontaneous mutation of Dock7 results in lower trabecular bone mass and impaired periosteal expansion in aged female Misty mice.

Authors:  Phuong T Le; Kathleen A Bishop; David E Maridas; Katherine J Motyl; Daniel J Brooks; Kenichi Nagano; Roland Baron; Mary L Bouxsein; Clifford J Rosen
Journal:  Bone       Date:  2017-08-15       Impact factor: 4.398

5.  Blocking FSH induces thermogenic adipose tissue and reduces body fat.

Authors:  Peng Liu; Yaoting Ji; Tony Yuen; Elizabeth Rendina-Ruedy; Victoria E DeMambro; Samarth Dhawan; Wahid Abu-Amer; Sudeh Izadmehr; Bin Zhou; Andrew C Shin; Rauf Latif; Priyanthan Thangeswaran; Animesh Gupta; Jianhua Li; Valeria Shnayder; Samuel T Robinson; Yue Eric Yu; Xingjian Zhang; Feiran Yang; Ping Lu; Yu Zhou; Ling-Ling Zhu; Douglas J Oberlin; Terry F Davies; Michaela R Reagan; Aaron Brown; T Rajendra Kumar; Solomon Epstein; Jameel Iqbal; Narayan G Avadhani; Maria I New; Henrik Molina; Jan B van Klinken; Edward X Guo; Christoph Buettner; Shozeb Haider; Zhuan Bian; Li Sun; Clifford J Rosen; Mone Zaidi
Journal:  Nature       Date:  2017-05-24       Impact factor: 49.962

6.  Connecting Bone and Fat: The Potential Role for Sclerostin.

Authors:  Heather Fairfield; Clifford J Rosen; Michaela R Reagan
Journal:  Curr Mol Biol Rep       Date:  2017-04-18

7.  IGFBP4 Is Required for Adipogenesis and Influences the Distribution of Adipose Depots.

Authors:  David E Maridas; Victoria E DeMambro; Phuong T Le; Subburaman Mohan; Clifford J Rosen
Journal:  Endocrinology       Date:  2017-10-01       Impact factor: 4.736

8.  A novel mouse model overexpressing Nocturnin results in decreased fat mass in male mice.

Authors:  Phuong T Le; Sheila A Bornstein; Katherine J Motyl; Li Tian; Jeremy J Stubblefield; Hee-Kyung Hong; Joseph S Takahashi; Carla B Green; Clifford J Rosen; Anyonya R Guntur
Journal:  J Cell Physiol       Date:  2019-04-05       Impact factor: 6.384

Review 9.  Skeletal effects of growth hormone and insulin-like growth factor-I therapy.

Authors:  Richard C Lindsey; Subburaman Mohan
Journal:  Mol Cell Endocrinol       Date:  2015-09-25       Impact factor: 4.102

Review 10.  Role of IGF1 and EFN-EPH signaling in skeletal metabolism.

Authors:  Richard C Lindsey; Charles H Rundle; Subburaman Mohan
Journal:  J Mol Endocrinol       Date:  2018-03-26       Impact factor: 5.098

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.